Homozygosity for the C→T polymorphism at nucleotide 46 in the 5′ untranslated region of the factor XII gene protects from development of acute coronary syndrome
Open Access
- 20 December 2001
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 115 (4) , 1007-1009
- https://doi.org/10.1046/j.1365-2141.2001.03201.x
Abstract
Recently, a C→T polymorphism at nucleotide 46 in the 5′‐untranslated region of the factor XII (FXII) gene was shown to be associated with lower levels of FXII. To study the impact of this polymorphism on the development of an acute coronary syndrome (ACS), we compared 303 patients with ACS and 227 patients with stable coronary artery disease (CAD). In the latter group, 54·2% of individuals carried wild‐type FXII:46C, 37·9% were heterozygous FXII:C46T and 7·9% were homozygous for FXII:46T. In contrast, in the ACS group (n = 303), 54·1% were wild‐type FXII:46C, 42·6% were heterozygous FXII:C46T and only 3·3% carried the homozygous FXII:46T genotype. The 2·5‐fold lower prevalence of the FXII:46T genotype in patients with ACS could indicate a protective effect on the development of ACS (odds ratio = 0·4, 95% CI 0·1–0·9) in patients with pre‐existing CAD.Keywords
This publication has 12 references indexed in Scilit:
- A Common C→T Polymorphism at nt 46 in the Promoter Region of Coagulation Factor XII is Associated With Decreased Factor XII ActivityThrombosis Research, 2001
- Epidemiological and Genetic Associations of Activated Factor XII Concentration With Factor VII Activity, Fibrinopeptide A Concentration, and Risk of Coronary Heart Disease in MenCirculation, 2000
- A Classification of Unstable Angina RevisitedCirculation, 2000
- FXII (46C→T) Polymorphism and In Vivo Generation of FXII ActivityThrombosis and Haemostasis, 1999
- A Common Genetic Polymorphism (46 C to T Substitution) in the 5′-Untranslated Region of the Coagulation Factor XII Gene Is Associated With Low Translation Efficiency and Decrease in Plasma Factor XII LevelBlood, 1998
- Levels of Activated FXII in Survivors of Myocardial Infarction – Association with Circulating Risk Factors and Extent of Coronary Artery DiseaseThrombosis and Haemostasis, 1998
- Hemostatic Effects of Oral Contraceptives in Women who Developed Deep-vein Thrombosis while Using Oral ContraceptivesThrombosis and Haemostasis, 1998
- Risk of Coronary Heart Disease and Activation of Factor XII in Middle-Aged MenArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia StudyBritish Journal of Haematology, 1994
- Thromboembolism and Bleeding Tendency in Congenital Factor XII DeficienCy - A Study on 74 Subjects from 14 Swiss FamiliesThrombosis and Haemostasis, 1991